4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-015888
Options or other derivatives
- Chief Medical Officer acquired 82,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gordon David N. · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-01 | Grant or award : show line 1 in the form Restricted stock units | +82,400 | 82,400 | D |
Loading xslF345X03/doc4.xml…